Literature DB >> 26559835

HIV-1 Virion Production from Single Inducible Proviruses following T-Cell Activation Ex Vivo.

John K Bui1, John W Mellors2, Anthony R Cillo1.   

Abstract

Quantifying induced virion production from single proviruses is important for assessing the effects of HIV-1 latency reversal agents. Limiting dilution ex vivo cultures of resting CD4(+) T cells from 14 HIV-positive volunteers revealed that virion production after T-cell activation from individual proviruses varies by 10,000-fold to 100,000-fold. High-producing proviruses were associated with increases in cell-associated HIV-1 DNA levels, suggesting that reactivated proviruses proliferate. Single-cell analyses are needed to investigate differences in proviral expansion and virus production following latency reversal.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559835      PMCID: PMC4719601          DOI: 10.1128/JVI.02520-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  Pairing computation with experimentation: a powerful coupling for understanding T cell signalling.

Authors:  Arup K Chakraborty; Jayajit Das
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

2.  Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.

Authors:  W P Tsai; S R Conley; H F Kung; R R Garrity; P L Nara
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

Review 3.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

4.  Expression of programmed death 1 ligands by murine T cells and APC.

Authors:  Tomohide Yamazaki; Hisaya Akiba; Hideyuki Iwai; Hironori Matsuda; Mami Aoki; Yuka Tanno; Tahiro Shin; Haruo Tsuchiya; Drew M Pardoll; Ko Okumura; Miyuki Azuma; Hideo Yagita
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

5.  Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.

Authors:  Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard T Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model.

Authors:  Liang Shan; Hung-Chih Yang; S Alireza Rabi; Hector C Bravo; Neeta S Shroff; Rafael A Irizarry; Hao Zhang; Joseph B Margolick; Janet D Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

7.  Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma.

Authors:  Anthony R Cillo; Amrita Krishnan; Ronald T Mitsuyasu; Deborah K McMahon; Shirley Li; John J Rossi; John A Zaia; John W Mellors
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

8.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

Authors:  Ya-Chi Ho; Liang Shan; Nina N Hosmane; Jeffrey Wang; Sarah B Laskey; Daniel I S Rosenbloom; Jun Lai; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

10.  Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.

Authors:  Datsen George Wei; Vicki Chiang; Elizabeth Fyne; Mini Balakrishnan; Tiffany Barnes; Michael Graupe; Joseph Hesselgesser; Alivelu Irrinki; Jeffrey P Murry; George Stepan; Kirsten M Stray; Angela Tsai; Helen Yu; Jonathan Spindler; Mary Kearney; Celsa A Spina; Deborah McMahon; Jacob Lalezari; Derek Sloan; John Mellors; Romas Geleziunas; Tomas Cihlar
Journal:  PLoS Pathog       Date:  2014-04-10       Impact factor: 6.823

View more
  16 in total

1.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

2.  International AIDS Society global scientific strategy: towards an HIV cure 2016.

Authors:  Steven G Deeks; Sharon R Lewin; Anna Laura Ross; Jintanat Ananworanich; Monsef Benkirane; Paula Cannon; Nicolas Chomont; Daniel Douek; Jeffrey D Lifson; Ying-Ru Lo; Daniel Kuritzkes; David Margolis; John Mellors; Deborah Persaud; Joseph D Tucker; Françoise Barre-Sinoussi; Galit Alter; Judith Auerbach; Brigitte Autran; Dan H Barouch; Georg Behrens; Marina Cavazzana; Zhiwei Chen; Éric A Cohen; Giulio Maria Corbelli; Serge Eholié; Nir Eyal; Sarah Fidler; Laurindo Garcia; Cynthia Grossman; Gail Henderson; Timothy J Henrich; Richard Jefferys; Hans-Peter Kiem; Joseph McCune; Keymanthri Moodley; Peter A Newman; Monique Nijhuis; Moses Supercharger Nsubuga; Melanie Ott; Sarah Palmer; Douglas Richman; Asier Saez-Cirion; Matthew Sharp; Janet Siliciano; Guido Silvestri; Jerome Singh; Bruno Spire; Jeffrey Taylor; Martin Tolstrup; Susana Valente; Jan van Lunzen; Rochelle Walensky; Ira Wilson; Jerome Zack
Journal:  Nat Med       Date:  2016-07-11       Impact factor: 53.440

3.  Principles Governing Establishment versus Collapse of HIV-1 Cellular Spread.

Authors:  Jason M Hataye; Joseph P Casazza; Katharine Best; C Jason Liang; Taina T Immonen; David R Ambrozak; Samuel Darko; Amy R Henry; Farida Laboune; Frank Maldarelli; Daniel C Douek; Nicolas W Hengartner; Takuya Yamamoto; Brandon F Keele; Alan S Perelson; Richard A Koup
Journal:  Cell Host Microbe       Date:  2019-11-21       Impact factor: 21.023

4.  Probabilistic control of HIV latency and transactivation by the Tat gene circuit.

Authors:  Youfang Cao; Xue Lei; Ruy M Ribeiro; Alan S Perelson; Jie Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

5.  Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency.

Authors:  Todd Bradley; Guido Ferrari; Barton F Haynes; David M Margolis; Edward P Browne
Journal:  Cell Rep       Date:  2018-10-02       Impact factor: 9.423

Review 6.  Mathematical Models of HIV Latency.

Authors:  Alison L Hill
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Blood biomarkers of expressed and inducible HIV-1.

Authors:  Anthony R Cillo; Francis Hong; Angela Tsai; Alivelu Irrinki; Jasmine Kaur; Derek D Sloan; Mattie Follen; Romas Geleziunas; Tomas Cihlar; Sandra S Win; Jeffrey P Murry; John W Mellors
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

Review 8.  Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.

Authors:  Timothy J Henrich; Steven G Deeks; Satish K Pillai
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

9.  Simulating within host human immunodeficiency virus 1 genome evolution in the persistent reservoir.

Authors:  Bradley R Jones; Jeffrey B Joy
Journal:  Virus Evol       Date:  2020-11-23

10.  Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.

Authors:  Alison L Hill; Daniel I S Rosenbloom; Edward Goldstein; Emily Hanhauser; Daniel R Kuritzkes; Robert F Siliciano; Timothy J Henrich
Journal:  PLoS Pathog       Date:  2016-04-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.